MICHAL BROOKS: Open Payments
NPI 1710143284 · MORRISTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,296 in 69 payments from 25 companies in 2025. Trend: 2023 $1,095 · 2024 $1,672 · 2025 $1,296
Food & beverage: $1,296
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $212 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| Sumitomo Pharma America, Inc. | 5 | $87 |
| ABBVIE INC. | 5 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $81 |
| Axsome Therapeutics, Inc. | 4 | $68 |
| Ardelyx, Inc. | 3 | $56 |
| Viatris Specialty LLC | 3 | $55 |
| Lundbeck LLC | 3 | $50 |
| GlaxoSmithKline, LLC. | 3 | $49 |
Products named: Ozempic, LEQVIO, GEMTESA, CAPLYTA, IBSRELA, YUPELRI, Auvelity, Rybelsus.
Industry payments across TN — which companies pay providers there.
